Skip to main content
. Author manuscript; available in PMC: 2019 Jul 2.
Published in final edited form as: Mol Pharm. 2018 Jun 4;15(7):2721–2731. doi: 10.1021/acs.molpharmaceut.8b00237

Figure 7. Schematic of multivalent targeting against CCR2 receptors and the observed effects on cellular migration and macrophage polarization.

Figure 7.

Multivalent display of 58C-scFv enhanced inhibition of cellular migration and increased M1 polarization of macrophages compared to monomeric, free 58C-scFv.